Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Modulation of Gut Microbiome and Autism Symptoms of ASD Children Supplemented with Biological Response Modifier: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study

J. Hrnciarova, K. Kubelkova, V. Bostik, I. Rychlik, D. Karasova, V. Babak, M. Datkova, K. Simackova, A. Macela

. 2024 ; 16 (13) : . [pub] 20240621

Language English Country Switzerland

Document type Journal Article, Randomized Controlled Trial

Persistent link   https://www.medvik.cz/link/bmc24019975

Grant support
0 Ministry of Defence of the Czech Republic - long-term organization development plan Medical Aspects of Weapons of Mass Destruction of the Faculty of Military Health Sciences, University of Defence

The etiology and mechanisms of autism and autism spectrum disorder (ASD) are not yet fully understood. There is currently no treatment for ASD for providing significant improvement in core symptoms. Recent studies suggest, however, that ASD is associated with gut dysbiosis, indicating that modulation of gut microbiota in children with ASD may thus reduce the manifestation of ASD symptoms. The aim of this pilot study (prospective randomized, double-blinded, placebo-controlled) was to evaluate efficacy of the biological response modifier Juvenil in modulating the microbiome of children with ASD and, in particular, whether Juvenil is able to alleviate the symptoms of ASD. In total, 20 children with ASD and 12 neurotypical children were included in our study. Supplementation of ASD children lasted for three months. To confirm Juvenil's impact on the gut microbiome, stool samples were collected from all children and the microbiome's composition was analyzed. This pilot study demonstrated that the gut microbiome of ASD children differed significantly from that of healthy controls and was converted by Juvenil supplementation toward a more neurotypical microbiome that positively modulated children's autism symptoms.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019975
003      
CZ-PrNML
005      
20241024110836.0
007      
ta
008      
241015s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/nu16131988 $2 doi
035    __
$a (PubMed)38999736
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Hrnciarova, Jela $u Faculty of Medicine, Charles University, 500 03 Hradec Kralove, Czech Republic $u Department of Psychiatry, University Hospital in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000185301344
245    10
$a Modulation of Gut Microbiome and Autism Symptoms of ASD Children Supplemented with Biological Response Modifier: A Randomized, Double-Blinded, Placebo-Controlled Pilot Study / $c J. Hrnciarova, K. Kubelkova, V. Bostik, I. Rychlik, D. Karasova, V. Babak, M. Datkova, K. Simackova, A. Macela
520    9_
$a The etiology and mechanisms of autism and autism spectrum disorder (ASD) are not yet fully understood. There is currently no treatment for ASD for providing significant improvement in core symptoms. Recent studies suggest, however, that ASD is associated with gut dysbiosis, indicating that modulation of gut microbiota in children with ASD may thus reduce the manifestation of ASD symptoms. The aim of this pilot study (prospective randomized, double-blinded, placebo-controlled) was to evaluate efficacy of the biological response modifier Juvenil in modulating the microbiome of children with ASD and, in particular, whether Juvenil is able to alleviate the symptoms of ASD. In total, 20 children with ASD and 12 neurotypical children were included in our study. Supplementation of ASD children lasted for three months. To confirm Juvenil's impact on the gut microbiome, stool samples were collected from all children and the microbiome's composition was analyzed. This pilot study demonstrated that the gut microbiome of ASD children differed significantly from that of healthy controls and was converted by Juvenil supplementation toward a more neurotypical microbiome that positively modulated children's autism symptoms.
650    _2
$a lidé $7 D006801
650    12
$a střevní mikroflóra $7 D000069196
650    _2
$a pilotní projekty $7 D010865
650    _2
$a dvojitá slepá metoda $7 D004311
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a ženské pohlaví $7 D005260
650    12
$a poruchy autistického spektra $x mikrobiologie $7 D000067877
650    _2
$a dítě $7 D002648
650    12
$a potravní doplňky $7 D019587
650    _2
$a feces $x mikrobiologie $7 D005243
650    _2
$a předškolní dítě $7 D002675
650    _2
$a prospektivní studie $7 D011446
650    _2
$a autistická porucha $x mikrobiologie $7 D001321
650    _2
$a dysbióza $x mikrobiologie $7 D064806
655    _2
$a časopisecké články $7 D016428
655    _2
$a randomizované kontrolované studie $7 D016449
700    1_
$a Kubelkova, Klara $u Military Faculty of Medicine, University of Defence, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Bostik, Vanda $u Military Faculty of Medicine, University of Defence, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Rychlik, Ivan $u Veterinary Research Institute, 621 00 Brno, Czech Republic
700    1_
$a Karasova, Daniela $u Veterinary Research Institute, 621 00 Brno, Czech Republic
700    1_
$a Babak, Vladimir $u Veterinary Research Institute, 621 00 Brno, Czech Republic $1 https://orcid.org/0000000208261075
700    1_
$a Datkova, Magdalena $u Faculty of Medicine, Charles University, 500 03 Hradec Kralove, Czech Republic $u Department of Psychiatry, University Hospital in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Simackova, Katerina $u Faculty of Medicine, Charles University, 500 03 Hradec Kralove, Czech Republic $u Department of Psychiatry, University Hospital in Hradec Kralove, 500 03 Hradec Kralove, Czech Republic
700    1_
$a Macela, Ales $u Military Faculty of Medicine, University of Defence, 500 03 Hradec Kralove, Czech Republic $1 https://orcid.org/0000000200427560 $7 mzk2005279505
773    0_
$w MED00189563 $t Nutrients $x 2072-6643 $g Roč. 16, č. 13 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38999736 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024110830 $b ABA008
999    __
$a ok $b bmc $g 2202295 $s 1231948
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 16 $c 13 $e 20240621 $i 2072-6643 $m Nutrients $n Nutrients $x MED00189563
GRA    __
$a 0 $p Ministry of Defence of the Czech Republic - long-term organization development plan Medical Aspects of Weapons of Mass Destruction of the Faculty of Military Health Sciences, University of Defence
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Archiving options